Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000150820 | SCV000198355 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Val552Met in exon 11 of HPS4: This variant is not expected to have clinical sign ificance because it has been identified in 31.2% (1373/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs5752330). |
Prevention |
RCV000150820 | SCV000313932 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000267065 | SCV000437647 | benign | Hermansky-Pudlak syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001519475 | SCV001728349 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001519475 | SCV001915137 | benign | not provided | 2018-11-12 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701684 | SCV001933095 | benign | Hermansky-Pudlak syndrome 4 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001519475 | SCV005273811 | benign | not provided | criteria provided, single submitter | not provided |